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Abstract
Introduction
Studies show that the recommendations of a primary 
care physician for colorectal cancer screening may be one 
important influence on an individual’s use of screening. 
However, another possible influence, the effect of regional 
differences in physicians’ beliefs and recommendations on 
screening use, has not been assessed.
Methods
We  linked  data  from  the  National  Health  Interview 
Survey on the use of colorectal cancer screening by respon-
dents aged 50 years or older, by hospital-referral region, 
with data from the Survey of Colorectal Cancer Screening 
Practices on the colorectal cancer screening recommenda-
tions of primary care physicians, by region. Our principal 
independent variables were the proportion of physicians in 
a region who recommended screening at age 50 and con-
tinuing screening at the recommended frequency.
Results
On average, 53.3% of physicians in a region correctly 
recommended initiating colorectal cancer screening, and 
64.8% advised screening at the recommended frequency. 
Of adults who lived in regions where less than 30% of phy-
sicians correctly recommended initiating screening, 47.3% 
had been screened, in contrast to 54.8% in areas where 
70%  or  more  of  physicians  made  correct  recommenda-
tions. Seventy-one percent of respondents living in regions 
where less than 30% of physicians advised screening at the 
recommended frequency were current on screening, in con-
trast to 79.9% of respondents living in regions where 70% 
or more of physicians made this recommendation. These 
differences were statistically significant after adjustment 
for individual characteristics.
Conclusion
Strategies to improve colorectal cancer screening recom-
mendations of primary care physicians may improve the 
use of screening for millions of Americans.
Introduction
Mortality from colorectal cancer (CRC), the third most 
common cancer in the United States, can be prevented by 
early detection (1). For this reason, screening for CRC is 
strongly endorsed by national professional societies and 
expert panels (2-5). Despite the public health importance 
of CRC screening, however, it remains widely underused 
(6,7).  Limited  patient  awareness  and  lack  of  physician 
recommendations during a health care visit are both bar-
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riers to CRC screening (8-11). Because several established 
options  for  CRC  screening  exist  (e.g.,  fecal  occult  blood 
testing  [FOBT],  sigmoidoscopy,  colonoscopy),  physicians 
may be unsure about how best to implement screening. 
Survey data show that primary care physicians commonly 
report CRC screening practices that are inconsistent with 
current guidelines (12). Screening practices may, there-
fore, vary by region (13).
The goal of our analysis was to examine whether regional 
variations in the beliefs and recommendations of primary 
care physicians about CRC screening are associated with 
regional levels of screening use. The conceptual framework 
for  this  study  is  derived  from  the  expanded  behavioral 
model of health care that incorporates the role of contex-
tual variables on health care use (14,15). We hypothesized 
that people living in an area where more primary care 
physicians  recommend  CRC  screening  consistent  with 
national guidelines would be more likely to use and be 
current on screening, after accounting for the individual 
characteristics associated with screening use.
Methods
Data 
Our  analysis  is  based  on  data  from  the  2000  and 
2003 National Health Interview Surveys (NHIS) and the 
National  Cancer  Institute’s  (NCI)  1999–2000  Survey  of 
Colorectal Cancer Screening Practices (SCCSP), Primary 
Care Physician Questionnaire (12). The NHIS, conducted 
by the National Center for Health Statistics of the Centers 
for Disease Control and Prevention (CDC), is nationally 
representative and collects information about demograph-
ic characteristics, chronic health conditions, health insur-
ance, and health behaviors of the civilian, noninstitution-
alized U.S. population (www.cdc.gov/nchs/nhis.htm). The 
NHIS Cancer Control Supplement, administered in 2000 
and 2003, includes a series of questions about the use of 
CRC screening (16).
The SCCSP, conducted by NCI, CDC, and the Centers 
for Medicare and Medicaid Services, surveyed a nationally 
representative  sample  of  1235  practicing  primary  care 
physicians  for  1999–2000,  including  family  and  general 
practitioners,  general  internists,  and  obstetricians  and 
gynecologists (8,12). The survey was designed to estimate 
CRC screening capacity and the knowledge and beliefs of 
primary care physicians about CRC screening. Details of 
the sampling scheme and a description of the characteris-
tics of the respondents have been published (12).
We  merged  data  from  the  NHIS  with  data  from  the 
SCCSP at the county level. These data were then aggre-
gated to hospital-referral regions, which represent region-
al health care markets for medical care and have been 
used extensively to examine regional variation in health 
care use (17-24). The United States has 306 hospital-refer-
ral regions (17). We constructed independent variables to 
reflect the recommendations of primary care physicians 
in the region where each respondent lived. Because of the 
confidential nature of these data, analyses were conducted 
at the Research Data Center of the National Center for 
Health Statistics.
Sample 
We included data on individuals from the NHIS who 
were aged at least 50 years, had not previously received 
a diagnosis of CRC, and responded to questions regarding 
the use of CRC screening. Because the sampling frames of 
the NHIS and the SCCSP were not identical, we limited 
our sample to individuals who lived in a hospital-referral 
region where four or more primary care physicians were 
surveyed in the SCCSP (N = 12,727 individuals in 122 
hospital-referral regions).
Outcome variables 
NHIS respondents were asked several questions about 
their use of CRC screening: if they had ever had an FOBT 
using a home test kit and, if so, the timing of their most 
recent home FOBT; if they had ever had a CRC screening 
test by sigmoidoscopy or colonoscopy and, if so, the type of 
test and the timing of their most recent test. Individuals 
were classified as “ever screened” for colorectal cancer if 
they reported ever taking a home FOBT, having had a sig-
moidoscopy, or having had a colonoscopy. We also examined 
whether subjects who had reported CRC screening were 
current  on  screening,  (i.e.,  home  FOBT  during  the  past 
year, sigmoidoscopy within the past 5 years, or colonos-
copy within the past 10 years [2]). NHIS did not ask about 
barium  enema.  Although  the  American  Cancer  Society 
includes double contrast barium enema every 5 years as 
an  acceptable  screening  option  (3),  the  U.S.  Preventive 
Services Task Force did not find direct evidence that this 
method is effective in reducing CRC mortality (2).
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We used data from the NHIS to define individual char-
acteristics and included age, sex, race and ethnicity, edu-
cation,  health  insurance,  health-care-seeking  behavior, 
prior history of cancer other than CRC, number of chronic 
medical conditions, and number of behavioral risk factors 
for CRC. We categorized ethnicity as non-Hispanic white, 
non-Hispanic black, Hispanic, or other race and ethnicity. 
Educational  attainment  was  defined  as  less  than  high 
school graduation, high school graduate, some college, and 
college graduate. Health insurance categories were unin-
sured; Medicare with private supplemental insurance, or 
private insurance; Medicare without supplemental cover-
age;  and  Medicaid  or  dual  eligibility  for  Medicare  and 
Medicaid.  We  categorized  health-care–seeking  behavior 
according to whether an individual had a usual source of 
health care, evidenced by a visit to any health care pro-
fessional, including a dentist, in the past year. Chronic 
medical conditions included arthritis, peptic ulcer disease, 
chronic  lung  disease,  cardiovascular  disease,  hyperten-
sion, and diabetes. Behavioral risk factors for CRC includ-
ed current cigarette use, heavy drinking (consuming 60 or 
more alcoholic drinks per month for men and 30 or more 
for women), and lack of regular exercise (25-27).
Primary care physicians who participated in the SCCSP 
were asked at what age and how frequently they recom-
mended  each  CRC  screening  method  for  a  patient  at 
average risk (12). Physicians reporting the use of FOBT 
were asked whether they provided office-based or home 
tests. Because sensitivity is lower for a single office-based 
FOBT than for the home test, in which samples are col-
lected over 3 days (2,4), only a home test was considered 
adequate screening. We coded recommendations for ini-
tiation of each type of CRC screening as being in accor-
dance with screening guidelines if the physician reported 
recommending that patients begin having the test at age 
50 (2). We coded each physician’s belief about frequency of 
screening as being in accordance with the guidelines if the 
response was at the recommended interval for at least one 
type of CRC screening test. We aggregated all responses 
according to hospital-referral region to create two region-
level  measures  of  CRC  screening  practices:  1)  the  pro-
portion of primary care physicians in a hospital-referral 
region who recommended initiating CRC screening at age 
50 years, and 2) the proportion of these physicians who 
advised at least one screening test at the recommended 
interval. These two variables captured distinct informa-
tion supported by a correlation coefficient of only −0.04.
Statistical analysis 
Using the data on the individual as the unit of analy-
sis, we constructed multilevel logistic regression models 
to  examine  the  odds  of  undergoing  CRC  screening.  We 
based the models on the average proportion of primary 
care physicians in an individual’s hospital-referral region 
who  recommended  CRC  screening,  after  controlling  for 
individual  factors  associated  with  CRC  screening.  To 
reflect  the  greater  precision  of  estimates  from  hospital-
referral  regions  with  a  large  number  of  primary  care 
physicians responding, we adjusted NHIS survey sample 
weights  for  the  number  of  primary  care  physicians  per 
region. The odds ratios (OR) for region-level measures of 
physician recommendations were expressed for a 30-per-
centage-point increase in the proportion of primary care 
physicians  in  the  region  recommending  CRC  according 
to the guidelines. Models accounted for the clustering of 
individuals in regions and for the survey sample weights 
and were estimated with SAS 9.0 (SAS Institute, Cary, 
North Carolina). We based independent variables on prior 
work and on their statistical relationships with the depen-
dent  variable.  We  hypothesized  that  regional  physician 
belief about the age at initiation of CRC screening would 
be associated with the likelihood that an individual living 
in a region would ever be screened. We also hypothesized 
that regional physician recommendations about screening 
intervals would be associated with the likelihood that a 
patient would be current on screening and included this 
variable in this model. The final models included age, sex, 
race and ethnicity, education, insurance, usual source of 
care, prior diagnosis of cancer other than CRC, dental visit 
within the prior year, number of chronic health conditions, 
number of behavioral risk factors for CRC, year of NHIS 
survey, and relevant hospital-referral region measure.
Results
Factors associated with ever receiving CRC screening 
Only 50.2% of adults aged 50 years or older had ever 
been screened for CRC (Table 1). Hispanics were signifi-
cantly less likely than non-Hispanic whites to have been 
screened. Respondents with less than a college degree were 
less likely than college graduates to have been screened. 
Uninsured  respondents,  those  who  had  Medicare  with-
VOLUME 4: NO. 4
OCTOBER 2007
  www.cdc.gov/pcd/issues/2007/oct/06_0140.htm • Centers for Disease Control and Prevention  
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, 
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only 
and does not imply endorsement by any of the groups named above.VOLUME 4: NO. 4
OCTOBER 2007
out supplemental coverage, and those with Medicaid or 
who were dually eligible for Medicare and Medicaid were 
less likely than those with private insurance or Medicare 
plus a supplemental policy to have ever been screened. 
Respondents without a usual source of care were less likely 
than those with one to be screened. Respondents who had 
previously received a diagnosis of cancer were more likely 
than those with no diagnosis to have been screened. CRC 
screening increased with the number of chronic conditions, 
but decreased as the number of behavioral risk factors for 
CRC increased. CRC screening increased between 2000 
and 2003.
On average, 53.3% of primary care physicians in a hos-
pital-referral region recommended initiating CRC screen-
ing  at  age  50  (range  0%–100%).  In  regions  where  less 
than 30% of physicians recommended initiating screening 
at  age  50,  47.3%  of  respondents  had  been  screened,  in 
contrast to 54.8% of respondents in regions where 70% 
or more of physicians made this recommendation. After 
adjustment  for  individual  characteristics,  an  absolute 
increase of 30 percentage points (e.g., from 50% to 80% or 
20% to 50%) in the proportion of primary care physicians 
in a hospital-referral region who recommended initiating 
CRC screening at age 50 was associated with a higher 
prevalence of screening in that region (OR, 1.09; 95% CI, 
1.01–1.18).
Factors associated with current CRC screening 
Among respondents who had ever received CRC screen-
ing, 77.9% were current on screening (Table 2). Women 
were  less  likely  than  men  to  be  current  on  screening. 
Respondents who had some college education were less 
likely than those who had graduated from college to be 
current  on  screening.  We  found  no  association  between 
current CRC screening and race and ethnicity, insurance, 
prior diagnosis of cancer other than CRC, the number of 
chronic  health  conditions,  or  the  number  of  behavioral 
risk factors for CRC. Respondents without a usual source 
of care were less likely than those with one to be current 
on screening. The proportion of respondents who had been 
screened and were current on screening increased between 
2000 and 2003.
On average, 64.8% of primary care physicians in hospi-
tal-referral regions recommended at least one CRC screen-
ing test at the recommended interval (range 0%–100%). 
In regions where <30% of physicians advised screening at 
the recommended frequency, 70.7% of respondents were 
current on screening, in contrast to 79.9% of respondents 
living in areas where ≥70% of physicians made this recom-
mendation. After adjustment, an increase of 30 percent-
age points in the proportion of primary care physicians 
in a hospital-referral region who recommended at least 
one CRC screening test at the correct interval was associ-
ated with a higher prevalence of current screening in that 
region (OR, 1.19; 95% CI, 1.05–1.37).
Seventy-one  percent  of  physicians  who  correctly  indi-
cated  that  screening  should  begin  at  age  50  reported 
recommending at least one test at the correct interval. Of 
these physicians, 54.4% recommended initiating screening 
at age 50. Overall, 37.4% of physicians correctly recom-
mended both initiation and frequency.
Discussion
Our analysis adds to earlier work demonstrating region-
al variation in the use of CRC screening (13) by examin-
ing the relationship between CRC screening use and the 
recommendations of primary care physicians, by hospital-
referral region. Although higher proportions of physicians 
who correctly recommend CRC screening were associated 
with relatively small changes in the proportion of adults 
screened,  increases  in  correct  recommendations  would 
result in many more people being screened. For example, 
if in each hospital-referral region the proportion of pri-
mary care physicians who recommend initiating screen-
ing  at  age  50  years  increased  by  30  percentage  points, 
an estimated 1.5 million additional adults older than 50 
years  would  be  screened  (based  on  an  estimated  U.S. 
population of 77 million older than 50 years, derived from 
the  U.S.  Census  [www.census.gov/popest/national/asrh/
NC-EST2005/NC-EST2005-01.xls]).  Similarly,  a  30-per-
centage-point increase in the proportion of primary care 
physicians in each region who recommend screening at the 
correct interval could result in an additional 2.1 million 
people being current on screening.
Our work is consistent with earlier work suggesting that 
lack of provider counseling about CRC screening, rather 
than  poor  patient  acceptance,  is  associated  with  lower 
rates of screening (28,29). Patient recall of physician’s rec-
ommendations is one of the strongest predictors of cancer 
screening  (8-11,30).  Our  findings  suggest  that  popula-
tion-based  interventions  directed  at  the  CRC  screening 
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CRC screening use. Despite the endorsement of several 
influential  national  organizations  and  an  awareness  of 
the importance of CRC screening, however, many primary 
care physicians report screening practices that are incon-
sistent with the guidelines (12). Practice guidelines alone 
may be limited in their effect on physician behavior for 
several reasons, including lack of awareness, lack of agree-
ment with the recommendations, barriers to successfully 
implementing the guideline, and concerns about patient 
acceptance of the guideline (31).
Several studies suggest that office-based systems may 
improve  the  prevalence  of  CRC  screening  in  primary 
care  practices  (4,32-34).  One  successful  example,  which 
was intended to increase cancer screening among disad-
vantaged patients, was based on the assignment of office 
responsibilities and the use of a cancer-screening checklist 
with chart stickers (35). An intervention requiring quar-
terly feedback of a provider’s CRC screening rates was also 
associated with increases in screening (36,37). Although 
some  studies  suggest  that  local,  practice-based  physi-
cian-reminder systems may improve the delivery of CRC 
screening and other types of cancer prevention (4,32,33), 
our  results  suggest  a  role  for  regional  interventions  to 
increase provider compliance with guidelines. Information 
on the feasibility of these types of interventions is limited, 
however,  and  one  quality  improvement  program  imple-
mented by a managed care health plan to increase CRC 
screening was not successful (38). Outreach and educa-
tion by leaders in medical opinion (i.e., academic detail-
ing), however, have been shown to improve adherence to 
guidelines for preventing myocardial infarction and other 
medical conditions (39).
Our analysis has several limitations. The data do not 
allow us to examine the relationship between the recom-
mendations  of  an  individual’s  personal  physician  and 
that  individual’s  screening  behavior,  and  they  are  not 
intended  to  be  a  proxy  for  the  recommendations  of  a 
specific  physician.  Rather,  our  findings  reflect  regional 
differences in physician recommendations. Although both 
the NHIS and the SCCSP are nationally representative, 
we included only respondents who lived in hospital-refer-
ral regions that were sampled in both surveys, and our 
results may not be generalizable to individuals in other 
areas. Finally, although we selected data from the NHIS 
that were collected several years after the SCCSP data 
that we used, some of the individuals in the NHIS may 
have  been  screened  before  the  SCCSP  was  conducted. 
Unfortunately, NHIS does not allow identification of the 
precise year of a test.
Our  findings  indicate  that  regional  differences  in  the 
recommendations  of  primary  care  physicians  for  CRC 
screening are associated with differences in screening use 
by individuals. For this reason, increasing the use of CRC 
screening in the United States may require interventions 
to improve the beliefs and recommendations of primary 
care physicians about CRC screening.
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Tables
Table 1. Factors Associated With Ever Having Been Screened for Colorectal Cancer (CRC), United Statesa
Factor N
Ever Screened 
n (Weighted %) Adjusted ORb (95% CI)
Total 12,727  6289 (0.2) NA
Sex
Male 280 282 (0.9) Ref
Female 7447 716 (49.6) 0.9 (0.86-1.0)
Race/ethnicity
Non-Hispanic white 862 498 (4.6) Ref
Non-Hispanic black 1981 898 (46.9) 0.94 (0.82-1.08)
Hispanic, other race/ethnicity 284 802 (.6) 0.66 (0.6-0.78)
Educationb
<High school graduate 04 1114 (6.) 0.2 (0.4-0.62)
High school graduate 76 1718 (47.7) 0.69 (0.9-0.79)
Some college 029 1696 (6.6) 0.9 (0.80-1.09)
College graduate 2914 1721 (9.1) Ref
Health insuranceb
Uninsured 106 227 (22.0) 0.4 (0.4-0.69)
Medicare with private supplemental insurance, or private insur-
ance
849 468 (4.9) Ref
Medicare without supplemental insurance 1881 921 (0.1) 0.81 (0.69-0.94)
Medicaid or dually eligible for Medicare with Medicaid 1260 479 (7.0) 0.7 (0.47-0.68)
Usual source of careb
Yes 11,77  6120 (2.6) Ref
No 74  11 (1.0) 0.1 (0.24-0.41)
Ever diagnosed with cancer other than CRCb
Yes 146 99 (64.6) 1.8 (1.20-1.8)
No 11,21   (48.) Ref
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OR indicates odds ratio; CI, confidence interval; Ref, reference group; NA, not applicable; HRR, hospital-referral region. 
a Analysis of data associated with hospital-referral regions (HRR) from the National Health Interview Survey (2000, 200) and the Survey of Colorectal 
Cancer Screening Practices, Primary Care Physician Questionnaire (1999–2000). 
b Data missing for education (n = 14), health insurance (n = ), prior diagnosis of cancer other than CRC (n = 1), usual source of care (n =198), 
and behavioral risk factors (n = 27). Models adjusted for age, sex, race and ethnicity, education, insurance, usual source of care, prior diagnosis of cancer 
other than CRC, number of chronic health conditions, number of behavioral risk factors for colorectal cancer, year of NHIS survey participation, and propor-
tion of primary care physicians in HRRs who recommend CRC screening beginning at age 0 years. 
c Odds ratio expressed for a 0-percentage-point increase in the proportion of primary care physicians in an HRR who recommend CRC screening beginning 
at age 0 years. 
(Continued on next page)Factor N
Ever Screened 
n (Weighted %) Adjusted ORb (95% CI)
Number of chronic diseases
0 90  1480 (9.2) 1. (1.28-1.42)
1 994  2001 (1.1)
2 2791  171 (7.6)
≥3 2012  124 (62.4)
Behavioral risk factorsb
0 266  19 (60.) 0.78 (0.72-0.8)
1 7627  67 (48.8)
≥2 2110  914 (4.)
Primary care physicians in HRRs recommending CRC screening beginning at age 50 y
0%-29% 117   (47.) 1.09 (1.01-1.18)c
0%-49% 966 1947 (0.0)
0%-9% 66 1767 (0.)
60%-69% 1890  929 (49.2)
≥ 70% 2078 1122 (4.8)
NHIS participation year
2000 628  2982 (48.0) Ref
200 6489  16 (2.0) 1.1 (1.0-1.26)
 
OR indicates odds ratio; CI, confidence interval; Ref, reference group; NA, not applicable; HRR, hospital-referral region. 
a Analysis of data associated with hospital-referral regions (HRR) from the National Health Interview Survey (2000, 200) and the Survey of Colorectal 
Cancer Screening Practices, Primary Care Physician Questionnaire (1999–2000). 
b Data missing for education (n = 14), health insurance (n = ), prior diagnosis of cancer other than CRC (n = 1), usual source of care (n =198), 
and behavioral risk factors (n = 27). Models adjusted for age, sex, race and ethnicity, education, insurance, usual source of care, prior diagnosis of cancer 
other than CRC, number of chronic health conditions, number of behavioral risk factors for colorectal cancer, year of NHIS survey participation, and propor-
tion of primary care physicians in HRRs who recommend CRC screening beginning at age 0 years. 
c Odds ratio expressed for a 0-percentage-point increase in the proportion of primary care physicians in an HRR who recommend CRC screening beginning 
at age 0 years. 
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Table 2. Factors Associated With Being Current on Colorectal Cancer (CRC) Screening, United Statesa 
Factor N
Current Screening 
n (Weighted %) Adjusted ORb (95% CI)
Total 6298 489 (77.9) NA
Sex
Male 282 206 (80.) Ref
Female 716 280 (7.8) 0.76 (0.6-0.90)
Race/ethnicity
Non-Hispanic white 498 70 (78.) Ref
Non-Hispanic black 898 688 (74.8) 0.99 (0.76-1.28)
Hispanic, other race/ethnicity 802 6 (77.1) 1.09 (0.80-1.49)
Educationb
<High school graduate 1114 846 (74.1) 0.80 (0.60-1.0)
High school graduate 1718 122 (77.4) 0.88 (0.71-1.10)
Some college 1696 1282 (76.4) 0.78 (0.62-0.99)
College graduate 1721 1407 (81.8) Ref
Health Insuranceb
Uninsured 227 14 (66.7) 0.82 (0.1-1.2)
Medicare with private supplemental insurance 468 66 (78.) Ref
Medicare without supplemental insurance 921 707 (77.) 1.04 (0.81-1.2)
Medicaid or dually eligible for Medicare with Medicaid 479 69 (77.9) 1.17 (0.81-1.69)
Usual source of careb
Yes 6120 4786 (78.4) Ref
No 11 61 (47.1) 0.28 (0.17-0.47)
Ever diagnosed with cancer other than CRCb
Yes 99 792 (82.1) 1.26 (0.98-1.61)
No  4098 (77.2) Ref
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OR indicates odds ratio; CI, confidence interval; Ref, reference group; NA, not applicable; HHR, hospital-referral region. 
a Analysis of data associated with hospital-referral regions (HRR) from the National Health Interview Survey (2000 and 200) and the Survey of Colorectal 
Cancer Screening Practices, Primary Care Physician Questionnaire (1999–2000). 
b Data missing for education (n = 49), insurance (n = 1), usual source of care (n = 6), prior diagnosis of cancer other than CRC (n = 4), and behav-
ioral risk factors (n = 117). Models adjusted for age, sex, race and ethnicity, education, insurance, usual source of care, prior diagnosis of cancer other 
than CRC, number of chronic health conditions, number of behavioral risk factors for CRC, year of NHIS survey participation, and proportion of primary care 
physicians in HRRs who advised at least one CRC screening test at the recommended interval. 
c Odds ratio expressed for a 0-percentage-point increase in the proportion of primary care physicians in an HRR who recommend at least one CRC screen-
ing test at the recommended interval.
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Factor N
Current Screening 
n (Weighted %) Adjusted ORb (95% CI)
Number of chronic diseases
0 1480 1122 (76.0) 1.02 (0.9-1.10)
1 2001 16 (79.)
2 174 124 (78.1)
≥3 124 974 (77.4)
Behavioral risk factorsb
0 192 1276 (80.4) 0.9 (0.82-1.0)
1 67 284 (78.1)
≥2 914 68 (7.9)
Proportion of primary care physicians in HRRs recommending at least one CRC screening test at the recommended interval
0%-29% 86 62 (70.7) 1.19 (1.0-1.7)c
0%-49% 49 76 (76.7)
0%-9% 146 1176 (76.)
60%-69% 1468 116 (77.6)
>70% 270 214 (79.9)
NHIS participation year
 2000 2982 2242 (74.1) Ref
 200 16 261 (80.8) 1.4 (1.22–1.7)
 
OR indicates odds ratio; CI, confidence interval; Ref, reference group; NA, not applicable; HRR, hospital-referral region. 
a Analysis of data associated with hospital-referral regions (HRR) from the National Health Interview Survey (2000 and 200) and the Survey of Colorectal 
Cancer Screening Practices, Primary Care Physician Questionnaire (1999–2000). 
b Data missing for education (n = 49), insurance (n = 1), usual source of care (n = 6), prior diagnosis of cancer other than CRC (n = 4), and behav-
ioral risk factors (n = 117). Models adjusted for age, sex, race and ethnicity, education, insurance, usual source of care, prior diagnosis of cancer other 
than CRC, number of chronic health conditions, number of behavioral risk factors for CRC, year of NHIS survey participation, and proportion of primary care 
physicians in HRRs who advised at least one CRC screening test at the recommended interval. 
c Odds ratio expressed for a 0-percentage-point increase in the proportion of primary care physicians in an HRR who recommend at least one CRC screen-
ing test at the recommended interval.
Table 2. (continued) Factors Associated with Being Current on Colorectal Cancer (CRC) Screening,  United Statesa 